BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
39 hedge funds and large institutions have $15.3M invested in BRAINSTORM CELL THERAPUTC in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $17.7M → $15.3M (-$2.44M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
39
Holding in Top 10
–
Calls
$1.67M
Puts
$698K
Top Buyers
| 1 | +$318K | |
| 2 | +$178K | |
| 3 | +$165K | |
| 4 |
AHB
Abner Herrman & Brock
Jersey City,
New Jersey
|
+$108K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
+$104K |
Top Sellers
| 1 | -$2.05M | |
| 2 | -$85.7K | |
| 3 | -$40K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$31.8K |
| 5 |
Millennium Management
New York
|
-$30K |